Rising Knee And Hip Replacement Surgeries Driving The Market Due To Increasing Risk Of Post-Surgical Bone Complications Is Supporting Development Across The Avascular Necrosis Market

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Is The Expected Market Size Of The Avascular Necrosis Market In 2026 And How Much Will It Reach By 2030?

The avascular necrosis market size has experienced significant expansion over recent years. It is anticipated to increase from $0.89 billion in 2025 to $0.97 billion in 2026, achieving a compound annual growth rate (CAGR) of 9.5%. The historical growth of this market can be linked to factors like trauma-related bone injuries, excessive steroid use, alcohol intake, late diagnoses, and the rise in orthopedic surgeries.

The avascular necrosis market is anticipated to experience robust expansion over the coming years. Its valuation is set to reach $1.38 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 9.2%. Factors contributing to this growth during the forecast timeframe include the wider uptake of advanced imaging, ongoing research in regenerative medicine, an expanding aging population, the rising incidence of sports injuries, and innovations in orthopedics. Key developments anticipated within the forecast horizon encompass the increasing application of early diagnostic imaging, a greater embrace of joint-preserving treatments, the proliferation of minimally invasive surgical techniques, an expansion of physical rehabilitation initiatives, and an emphasis on interventions for early-stage disease.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24476&type=smp

Which Major Factors Are Contributing To The Development Of The Avascular Necrosis Market?

The avascular necrosis market is anticipated to expand due to the increasing volume of knee replacements and hip surgeries. These surgical interventions involve replacing damaged joints and providing pain relief for individuals suffering from severe avascular necrosis. The rising incidence of osteoarthritis, a condition that causes significant joint pain and impaired mobility, often necessitates such surgical procedures for relief and an improved quality of life, thereby contributing to the increase in knee and hip surgeries. Moreover, avascular necrosis itself, characterized by the death of bone tissue due to reduced blood supply, is a major factor in the demand for knee replacements and hip surgeries, frequently resulting in joint deterioration and collapse. For instance, in November 2024, the American Joint Replacement Registry (AJRR), a US-based registry managed by the American Academy of Orthopaedic Surgeons, reported that in 2023, the number of hip and knee arthroplasty procedures recorded in its registry exceeded 4 million, marking an 18% increase compared to 2022. Consequently, the growing number of knee replacements and hip surgeries is driving the growth of the avascular necrosis market.

How Is The Avascular Necrosis Market Distributed Across Key Segments?

The avascular necrosis market covered in this report is segmented –

1) By Type: Trauma Related Avascular Necrosis, Non-Trauma Related Avascular Necrosis

2) By Diagnosis: Imaging, Biopsy, Computed Tomography Scan, Positron Emission Tomography, X-Ray

3) By Treatment Type: Medications, Surgery, Physical Therapy, Lifestyle Changes, Bone Grafting

4) By End-User: Hospitals, Specialty Clinics, Rehabilitation Centers, Ambulatory Surgical Centers, Home Care Settings

Subsegments:

1) By Trauma-Related Avascular Necrosis: Fracture-Induced Avascular Necrosis, Dislocation-Induced Avascular Necrosis, Post-Surgical Avascular Necrosis, Crush Injury-Related Avascular Necrosis, Sports Injury-Associated Avascular Necrosis

2) By Non-Trauma Related Avascular Necrosis: Steroid-Induced Avascular Necrosis, Alcohol-Induced Avascular Necrosis, Sickle Cell Disease-Associated Avascular Necrosis, Lupus-Related Avascular Necrosis, Radiation Therapy-Induced Avascular Necrosis, Idiopathic Avascular Necrosis

Who Are The Major Companies Operating In The Avascular Necrosis Market?

Major companies operating in the avascular necrosis market are Stryker Corporation, Massachusetts General Hospital, Zimmer Biomet Holdings Inc., Smith & Nephew plc, Stanford Health Care, Apollo Hospitals Enterprise Limited, Singapore General Hospital Pte Ltd., Fortis Healthcare Limited, Narayana Hrudayalaya Limited, Bumrungrad International Hospital Co. Ltd., Aster DM Healthcare Limited, Mount Elizabeth Hospital Pte Ltd., Gleneagles Hospital Pte Ltd., Shalby Limited, Texas Orthopedic Hospital LLC, Regrow Biosciences Pvt. Ltd., Maxcure Hospitals Limited, Medicover Hospitals Private Limited, Mesoblast Limited, Athersys Inc.

Access The Complete Avascular Necrosis Market Report:

https://www.thebusinessresearchcompany.com/report/avascular-necrosis-global-market-report

Which Region Has The Strongest Presence In The Avascular Necrosis Market?

North America was the largest region in the avascular necrosis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the avascular necrosis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Avascular Necrosis Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/sample.aspx?id=24476&type=smp

Browse Through More Reports Similar to the Global Avascular Necrosis Market 2026, By The Business Research Company

Peripheral Artery Disease Market Report 2026

https://www.thebusinessresearchcompany.com/report/peripheral-artery-disease-global-market-report

Peripheral Arterial Disease Market Report 2026

https://www.thebusinessresearchcompany.com/report/peripheral-arterial-disease-global-market-report

Rare Inflammatory Disease Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/rare-inflammatory-disease-treatment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795